Privacy Implications of Social Media
Remarks of FTC Commissioner Julie Brill, U.S.-China Internet Industry Forum
Washington DC
Date
By
File
Privacy Implications of Social Media
(61.59 KB)
Displaying 2321 - 2340 of 4000
Prepared Statement of the Federal Trade Commission In Connection With Oversight of the Antitrust Enforcement Agencies
Before the Subcommittee on Intellectual Property, Competition, and the Internet of the Committee on the Judiciary, United States House of Representatives
Congressional Session
112th Congress
Date
By
Jon Leibowitz, Former Chairman
File
Testimony
(182.13 KB)
Privacy: A Lesson from the Playroom
Remarks of FTC Commissioner Julie Brill, IAPP Practical Privacy Series
Washington, DC
Date
By
File
Privacy: A Lesson from the Playroom
(65.72 KB)
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Dr. Gary Arbuckle and Ms. Amy Freeze, theoriginalncgdrops.com and resetthebody.com
Date
By
Mary K. Engle, Associate Director
Mary K. Engle
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Kevin Wright, HCG Platinum, LLC
Date
By
Mary K. Engle, Associate Director
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Richard Matmer, Nutri Fusion Systems LLC
Date
By
Mary K. Engle, Associate Director
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Greg Grimshaw, hcg-miracleweightloss.com
Date
By
Mary K. Engle, Associate Director
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Richard Matmer, Nutri Fusion Systems LLC
Date
By
Mary K. Engle, Associate Director
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Clint Ethington, HCG Diet Direct LLC
Date
By
Mary K. Engle, Associate Director
Statement of Commissioners Julie Brill, Jon Leibowitz and Edith Ramirez Regarding the Complaint and Proposed Consent Order
In re Pool Corporation
Date
Matter Number
1010115
By
Dissenting Statement of Commissioner J. Thomas Rosch in the Matter of Pool Corporation
FTC File No. 101-0115
Date
By
J. Thomas Rosch, Former Commissioner
Privacy and Consumer Protection in Social Media
Remarks of FTC Commissioner Julie Brill, North Carolina Law Review 2011 Symposium
Chapel Hill, North Carolina
Date
By
File
Remarks of FTC Chairman Jon Leibowitz As Prepared for Delivery
Fall Forum 2011
Date
By
Jon Leibowitz, Former Chairman
File
Accountable Care Organizations: What Exactly Are We Getting?
ABA Section of Antitrust Law Fall Forum
Date
By
J. Thomas Rosch, Former Commissioner
33rd Annual PMA Marketing Law Conference Keynote
Remarks of FTC Commissioner Julie Brill, PMA Marketing Law Conference
Chicago, IL
Date
By
File
Opinion: Proposed Legislation Does Not Treat All Sweetheart Drug Deals as Pay-for-Delay Deals
Letter to the Editor, published in POLITICO
Date
By
J. Thomas Rosch, Former Commissioner
At the Intersection of Online Advertising and Privacy: FTC Enforcement, Policy, and Encouragement of Self-Regulation
Remarks of FTC Chairman Jon Leibowitz as Prepared for Delivery, Ad:Tech NY 2011 Conference
New York, NY
Date
By
Jon Leibowitz, Former Chairman
Displaying 2321 - 2340 of 4000
Join us at the FTC!